These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16118640)

  • 1. A streamlined platform for high-content functional proteomics of primary human specimens.
    Jessani N; Niessen S; Wei BQ; Nicolau M; Humphrey M; Ji Y; Han W; Noh DY; Yates JR; Jeffrey SS; Cravatt BF
    Nat Methods; 2005 Sep; 2(9):691-7. PubMed ID: 16118640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
    Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of breast cancer for marker discovery and signal pathway profiling.
    Hondermarck H; Vercoutter-Edouart AS; Révillion F; Lemoine J; el-Yazidi-Belkoura I; Nurcombe V; Peyrat JP
    Proteomics; 2001 Oct; 1(10):1216-32. PubMed ID: 11721634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of breast carcinoma.
    Somiari RI; Somiari S; Russell S; Shriver CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].
    Gilabert M; Audebert S; Viens P; Borg JP; Bertucci F; Gonçalves A
    Bull Cancer; 2010 Mar; 97(3):321-39. PubMed ID: 20202919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT).
    Chen EI; Hewel J; Felding-Habermann B; Yates JR
    Mol Cell Proteomics; 2006 Jan; 5(1):53-6. PubMed ID: 16272560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
    Niu D; Feng H; Chen WN
    J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
    Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
    Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in oncoproteomics.
    Jain KK
    Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic investigation of intra-tumor heterogeneity using network-based contextualization - A case study on prostate cancer.
    Goh WWB; Zhao Y; Sue AC; Guo T; Wong L
    J Proteomics; 2019 Aug; 206():103446. PubMed ID: 31323421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.
    Mattie MD; Benz CC; Bowers J; Sensinger K; Wong L; Scott GK; Fedele V; Ginzinger D; Getts R; Haqq C
    Mol Cancer; 2006 Jun; 5():24. PubMed ID: 16784538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive modeling in proteomics-based disease detection.
    Pham TD
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts.
    Groessl M; Slany A; Bileck A; Gloessmann K; Kreutz D; Jaeger W; Pfeiler G; Gerner C
    J Proteome Res; 2014 Nov; 13(11):4773-82. PubMed ID: 25238572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
    Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
    J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteome analysis--basis for individualized pancreatic carcinoma therapy?].
    Löhr JM; Faissner R; Findeisen P; Neumaier M
    Internist (Berl); 2006 Jun; 47 Suppl 1():S40-8. PubMed ID: 16773365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
    Liang X; Zhao J; Hajivandi M; Wu R; Tao J; Amshey JW; Pope RM
    J Proteome Res; 2006 Oct; 5(10):2632-41. PubMed ID: 17022634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELDI-TOF-MS proteomics of breast cancer.
    Clarke CH; Buckley JA; Fung ET
    Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.